PG vs TPST · P/E 25, rev $84.28B vs $26.3M cap
Procter & Gamble Company (PG) versus Tempest Therapeutics Inc (TPST) — a side-by-side from cached financials, not a winner call.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Tempest Therapeutics Inc (TPST) is a biotechnology company listed on US.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
TPST does not have a complete income-statement cache yet.
PG currently screens at market cap $373.53B and trailing P/E 25.3. TPST currently screens at market cap $26.3M.
Not investment advice. Open the PG and TPST stock pages for the full models.
Not investment advice.